Skip to main content
. 2018 Nov 5;51(3):1086–1097. doi: 10.4143/crt.2018.537

Fig. 4.

Fig. 4.

Disease-free survival (A) and overall survival (B) according to the direction of change in programmed death ligand 1 (PD-L1) tumor proportion score following platinum-based neoadjuvant chemotherapy (NACT). HR, hazard ratio; CI, confidence interval.